BB Biotech AG (XSWX:BION) Buyback Yield %: 0.12 (As of Jun. 28, 2026) — 52% Below Median


XSWX:BION BB Biotech AG XSWX:BION
33 GF Score
Price CHF47.60
! 4 Warning Signs
View Full Analysis

What is BB Biotech AG Buyback Yield %?

BB Biotech AG XSWX:BION -0.42% 33 Buyback Yield % is 0.12 as of Jun. 28, 2026, which is 52% below its 10-year median of 0.25. GuruFocus rates XSWX:BION with a GF Score™ of 33/100. The stock has 4 warning signs investors should review. Among 743 Biotechnology companies, BB Biotech AG ranks better than 89.23% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

BB Biotech AG's current buyback yield was 0.12%.

BB Biotech AG Buyback Yield % Historical Data

* Premium members only.

The historical data trend for BB Biotech AG's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG Buyback Yield % Chart

BB Biotech AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.90 0.00 0.16 -0.52

BB Biotech AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.31 0.25 -0.52 0.13

XSWX:BION vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, BB Biotech AG's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BB Biotech AG Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Buyback Yield % falls into.


XSWX:BION
33GF Score
BB Biotech AG XSWX:BION
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

BB Biotech AG's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-5.037 + 17.884) / 2478.94755
=-0.52%

BB Biotech AG's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-3.102 + 0) / 2451.37305
=0.13%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.12 mean?
BB Biotech AG (XSWX:BION) has a Buyback Yield % of 0.12 as of Jun. 28, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on BB Biotech AG and its competitors. This is 52% below median its historical median of 0.25. According to the industry distribution chart, BB Biotech AG ranks #80 out of 743 companies in the Biotechnology industry, placing it in the top 10.8%.
Is BB Biotech AG's Buyback Yield % too high?
BB Biotech AG's current Buyback Yield % of 0.12 is 52% below median its 10-year median of 0.25. Based on the distribution chart, BB Biotech AG ranks #80 out of 743 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, BB Biotech AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #80 out of 743 companies for Buyback Yield %. This places BB Biotech AG in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current Buyback Yield % is 0.12, which is 52% below median its own 10-year median of 0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current Buyback Yield % of 0.12. The current Buyback Yield % is 0.12, which is 52% below median its 10-year median of 0.25. BB Biotech AG's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current Buyback Yield % is 0.12 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
33GF Score

Get the complete analysis for XSWX:BION

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF47.60
Price